Logo image of LRN

STRIDE INC (LRN) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:LRN - US86333M1080 - Common Stock

69.79 USD
-0.59 (-0.84%)
Last: 1/15/2026, 8:04:00 PM
69.9486 USD
+0.16 (+0.23%)
After Hours: 1/15/2026, 8:04:00 PM
Fundamental Rating

7

We assign a fundamental rating of 7 out of 10 to LRN. LRN was compared to 76 industry peers in the Diversified Consumer Services industry. LRN has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. LRN may be a bit undervalued, certainly considering the very reasonable score on growth This makes LRN very considerable for value and quality investing!


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

  • LRN had positive earnings in the past year.
  • LRN had a positive operating cash flow in the past year.
  • LRN had positive earnings in each of the past 5 years.
  • LRN had a positive operating cash flow in each of the past 5 years.
LRN Yearly Net Income VS EBIT VS OCF VS FCFLRN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M

1.2 Ratios

  • LRN's Return On Assets of 13.54% is amongst the best of the industry. LRN outperforms 88.16% of its industry peers.
  • LRN has a Return On Equity of 20.68%. This is amongst the best in the industry. LRN outperforms 85.53% of its industry peers.
  • LRN has a Return On Invested Capital of 16.01%. This is amongst the best in the industry. LRN outperforms 93.42% of its industry peers.
  • LRN had an Average Return On Invested Capital over the past 3 years of 11.97%. This is in line with the industry average of 10.30%.
  • The 3 year average ROIC (11.97%) for LRN is below the current ROIC(16.01%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 13.54%
ROE 20.68%
ROIC 16.01%
ROA(3y)10.13%
ROA(5y)8.29%
ROE(3y)16.74%
ROE(5y)14.46%
ROIC(3y)11.97%
ROIC(5y)10.27%
LRN Yearly ROA, ROE, ROICLRN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

1.3 Margins

  • LRN has a Profit Margin of 12.76%. This is in the better half of the industry: LRN outperforms 77.63% of its industry peers.
  • In the last couple of years the Profit Margin of LRN has grown nicely.
  • LRN has a better Operating Margin (17.83%) than 80.26% of its industry peers.
  • In the last couple of years the Operating Margin of LRN has grown nicely.
  • LRN has a Gross Margin of 39.20%. This is comparable to the rest of the industry: LRN outperforms 44.74% of its industry peers.
  • In the last couple of years the Gross Margin of LRN has grown nicely.
Industry RankSector Rank
OM 17.83%
PM (TTM) 12.76%
GM 39.2%
OM growth 3Y23.39%
OM growth 5Y41.07%
PM growth 3Y23.52%
PM growth 5Y38.44%
GM growth 3Y3.53%
GM growth 5Y3.28%
LRN Yearly Profit, Operating, Gross MarginsLRN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

8

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so LRN is creating value.
  • Compared to 1 year ago, LRN has more shares outstanding
  • Compared to 5 years ago, LRN has more shares outstanding
  • Compared to 1 year ago, LRN has an improved debt to assets ratio.
LRN Yearly Shares OutstandingLRN Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M
LRN Yearly Total Debt VS Total AssetsLRN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

2.2 Solvency

  • An Altman-Z score of 5.26 indicates that LRN is not in any danger for bankruptcy at the moment.
  • With an excellent Altman-Z score value of 5.26, LRN belongs to the best of the industry, outperforming 92.11% of the companies in the same industry.
  • The Debt to FCF ratio of LRN is 1.74, which is an excellent value as it means it would take LRN, only 1.74 years of fcf income to pay off all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 1.74, LRN belongs to the top of the industry, outperforming 80.26% of the companies in the same industry.
  • LRN has a Debt/Equity ratio of 0.32. This is a healthy value indicating a solid balance between debt and equity.
  • Looking at the Debt to Equity ratio, with a value of 0.32, LRN is in line with its industry, outperforming 52.63% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.32
Debt/FCF 1.74
Altman-Z 5.26
ROIC/WACC2.06
WACC7.78%
LRN Yearly LT Debt VS Equity VS FCFLRN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B

2.3 Liquidity

  • LRN has a Current Ratio of 6.77. This indicates that LRN is financially healthy and has no problem in meeting its short term obligations.
  • With an excellent Current ratio value of 6.77, LRN belongs to the best of the industry, outperforming 97.37% of the companies in the same industry.
  • A Quick Ratio of 6.69 indicates that LRN has no problem at all paying its short term obligations.
  • Looking at the Quick ratio, with a value of 6.69, LRN belongs to the top of the industry, outperforming 97.37% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 6.77
Quick Ratio 6.69
LRN Yearly Current Assets VS Current LiabilitesLRN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

6

3. Growth

3.1 Past

  • LRN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 17.82%, which is quite good.
  • Measured over the past years, LRN shows a very strong growth in Earnings Per Share. The EPS has been growing by 58.07% on average per year.
  • The Revenue has grown by 17.25% in the past year. This is quite good.
  • Measured over the past years, LRN shows a quite strong growth in Revenue. The Revenue has been growing by 18.24% on average per year.
EPS 1Y (TTM)17.82%
EPS 3Y33.5%
EPS 5Y58.07%
EPS Q2Q%48.94%
Revenue 1Y (TTM)17.25%
Revenue growth 3Y12.56%
Revenue growth 5Y18.24%
Sales Q2Q%12.67%

3.2 Future

  • Based on estimates for the next years, LRN will show a quite strong growth in Earnings Per Share. The EPS will grow by 12.74% on average per year.
  • LRN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.21% yearly.
EPS Next Y26.61%
EPS Next 2Y14.79%
EPS Next 3Y12.74%
EPS Next 5YN/A
Revenue Next Year5.92%
Revenue Next 2Y5.3%
Revenue Next 3Y4.99%
Revenue Next 5Y4.21%

3.3 Evolution

  • Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
LRN Yearly Revenue VS EstimatesLRN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B 2B 2.5B
LRN Yearly EPS VS EstimatesLRN Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2 4 6 8

9

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 10.77 indicates a reasonable valuation of LRN.
  • Compared to the rest of the industry, the Price/Earnings ratio of LRN indicates a rather cheap valuation: LRN is cheaper than 81.58% of the companies listed in the same industry.
  • LRN's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.54.
  • LRN is valuated reasonably with a Price/Forward Earnings ratio of 8.80.
  • LRN's Price/Forward Earnings ratio is rather cheap when compared to the industry. LRN is cheaper than 89.47% of the companies in the same industry.
  • When comparing the Price/Forward Earnings ratio of LRN to the average of the S&P500 Index (24.31), we can say LRN is valued rather cheaply.
Industry RankSector Rank
PE 10.77
Fwd PE 8.8
LRN Price Earnings VS Forward Price EarningsLRN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, LRN is valued cheaply inside the industry as 86.84% of the companies are valued more expensively.
  • Based on the Price/Free Cash Flow ratio, LRN is valued cheaply inside the industry as 92.11% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 9.81
EV/EBITDA 4.88
LRN Per share dataLRN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

  • LRN's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • LRN has an outstanding profitability rating, which may justify a higher PE ratio.
  • LRN's earnings are expected to grow with 12.74% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.4
PEG (5Y)0.19
EPS Next 2Y14.79%
EPS Next 3Y12.74%

0

5. Dividend

5.1 Amount

  • No dividends for LRN!.
Industry RankSector Rank
Dividend Yield 0%

STRIDE INC

NYSE:LRN (1/15/2026, 8:04:00 PM)

After market: 69.9486 +0.16 (+0.23%)

69.79

-0.59 (-0.84%)

Chartmill FA Rating
GICS IndustryGroupConsumer Services
GICS IndustryDiversified Consumer Services
Earnings (Last)10-28
Earnings (Next)01-27
Inst Owners111.2%
Inst Owner Change1.04%
Ins Owners3.06%
Ins Owner Change4.82%
Market Cap3.06B
Revenue(TTM)2.48B
Net Income(TTM)315.86M
Analysts82
Price Target128.82 (84.58%)
Short Float %12.51%
Short Ratio2.49
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-7.76%
Min EPS beat(2)-41.53%
Max EPS beat(2)26.01%
EPS beat(4)2
Avg EPS beat(4)-3.18%
Min EPS beat(4)-41.53%
Max EPS beat(4)26.01%
EPS beat(8)6
Avg EPS beat(8)44.6%
EPS beat(12)10
Avg EPS beat(12)44.76%
EPS beat(16)13
Avg EPS beat(16)18.17%
Revenue beat(2)2
Avg Revenue beat(2)1.75%
Min Revenue beat(2)0.16%
Max Revenue beat(2)3.34%
Revenue beat(4)4
Avg Revenue beat(4)2.14%
Min Revenue beat(4)0.16%
Max Revenue beat(4)3.34%
Revenue beat(8)7
Avg Revenue beat(8)2.35%
Revenue beat(12)11
Avg Revenue beat(12)2.73%
Revenue beat(16)15
Avg Revenue beat(16)2.74%
PT rev (1m)-4.41%
PT rev (3m)-24.28%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-14.95%
EPS NY rev (1m)4.86%
EPS NY rev (3m)-9.71%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-2.91%
Revenue NY rev (1m)-0.04%
Revenue NY rev (3m)-5.82%
Valuation
Industry RankSector Rank
PE 10.77
Fwd PE 8.8
P/S 1.24
P/FCF 9.81
P/OCF 8.08
P/B 2
P/tB 2.71
EV/EBITDA 4.88
EPS(TTM)6.48
EY9.28%
EPS(NY)7.93
Fwd EY11.37%
FCF(TTM)7.12
FCFY10.2%
OCF(TTM)8.64
OCFY12.38%
SpS56.43
BVpS34.82
TBVpS25.73
PEG (NY)0.4
PEG (5Y)0.19
Graham Number71.26
Profitability
Industry RankSector Rank
ROA 13.54%
ROE 20.68%
ROCE 21.12%
ROIC 16.01%
ROICexc 24.34%
ROICexgc 34.29%
OM 17.83%
PM (TTM) 12.76%
GM 39.2%
FCFM 12.61%
ROA(3y)10.13%
ROA(5y)8.29%
ROE(3y)16.74%
ROE(5y)14.46%
ROIC(3y)11.97%
ROIC(5y)10.27%
ROICexc(3y)20.97%
ROICexc(5y)16.99%
ROICexgc(3y)36.26%
ROICexgc(5y)30.39%
ROCE(3y)15.79%
ROCE(5y)13.55%
ROICexgc growth 3Y30.19%
ROICexgc growth 5Y48.22%
ROICexc growth 3Y36.36%
ROICexc growth 5Y54.51%
OM growth 3Y23.39%
OM growth 5Y41.07%
PM growth 3Y23.52%
PM growth 5Y38.44%
GM growth 3Y3.53%
GM growth 5Y3.28%
F-Score7
Asset Turnover1.06
Health
Industry RankSector Rank
Debt/Equity 0.32
Debt/FCF 1.74
Debt/EBITDA 0.87
Cap/Depr 57.81%
Cap/Sales 2.7%
Interest Coverage 44.78
Cash Conversion 68.05%
Profit Quality 98.82%
Current Ratio 6.77
Quick Ratio 6.69
Altman-Z 5.26
F-Score7
WACC7.78%
ROIC/WACC2.06
Cap/Depr(3y)56.69%
Cap/Depr(5y)59.43%
Cap/Sales(3y)3.07%
Cap/Sales(5y)3.32%
Profit Quality(3y)114.14%
Profit Quality(5y)117.4%
High Growth Momentum
Growth
EPS 1Y (TTM)17.82%
EPS 3Y33.5%
EPS 5Y58.07%
EPS Q2Q%48.94%
EPS Next Y26.61%
EPS Next 2Y14.79%
EPS Next 3Y12.74%
EPS Next 5YN/A
Revenue 1Y (TTM)17.25%
Revenue growth 3Y12.56%
Revenue growth 5Y18.24%
Sales Q2Q%12.67%
Revenue Next Year5.92%
Revenue Next 2Y5.3%
Revenue Next 3Y4.99%
Revenue Next 5Y4.21%
EBIT growth 1Y50.26%
EBIT growth 3Y38.88%
EBIT growth 5Y66.8%
EBIT Next Year35.87%
EBIT Next 3Y15.81%
EBIT Next 5Y18.08%
FCF growth 1Y115.04%
FCF growth 3Y38.85%
FCF growth 5Y60.14%
OCF growth 1Y79.65%
OCF growth 3Y27.9%
OCF growth 5Y40.03%

STRIDE INC / LRN FAQ

What is the ChartMill fundamental rating of STRIDE INC (LRN) stock?

ChartMill assigns a fundamental rating of 7 / 10 to LRN.


What is the valuation status of STRIDE INC (LRN) stock?

ChartMill assigns a valuation rating of 9 / 10 to STRIDE INC (LRN). This can be considered as Undervalued.


How profitable is STRIDE INC (LRN) stock?

STRIDE INC (LRN) has a profitability rating of 8 / 10.


What is the expected EPS growth for STRIDE INC (LRN) stock?

The Earnings per Share (EPS) of STRIDE INC (LRN) is expected to grow by 26.61% in the next year.


Can you provide the dividend sustainability for LRN stock?

The dividend rating of STRIDE INC (LRN) is 0 / 10 and the dividend payout ratio is 0%.